Oral Administration: Pills and Liquids
Many common Alzheimer's medications, particularly those for managing symptoms, are taken orally as tablets, capsules, or liquids. Examples include cholinesterase inhibitors like donepezil (Aricept) and galantamine (Razadyne), which help with memory and thinking, and glutamate regulators like memantine (Namenda) for moderate to severe Alzheimer's [1]. A combination drug (Namzaric) is also available in an extended-release oral form [1].
Challenges with oral administration
As Alzheimer's progresses, memory problems can lead to missed doses, and difficulty swallowing or confusion can cause resistance [1]. Caregivers can use strategies like pill organizers, establishing routines, or, after consulting a pharmacist, crushing certain pills [1].
Transdermal Patches: A Convenient Alternative
Transdermal patches, such as the rivastigmine (Exelon) patch, deliver medication through the skin over 24 hours [1]. This method can lead to fewer gastrointestinal side effects compared to oral medications and may improve adherence [1]. It also provides consistent drug levels [1]. Caregivers need to apply a new patch daily to a clean, dry area and rotate sites to avoid skin irritation [1].
Intravenous (IV) Infusions: For Newer Therapies
Newer monoclonal antibody treatments, like lecanemab (Leqembi) and donanemab (Kisunla), designed to slow early-stage Alzheimer's progression, are given via IV infusion in a healthcare setting [1].
The IV infusion process
Infusions are typically administered every two or four weeks and last about an hour [1]. They require medical supervision to monitor for side effects, including potential brain swelling or bleeding (amyloid-related imaging abnormalities, or ARIA) [1]. This method requires regular visits to an infusion center or clinic [1].
Comparison of Administration Methods
| Feature | Oral Medications | Transdermal Patches | Intravenous (IV) Infusions |
|---|---|---|---|
| Examples | Donepezil, Galantamine, Memantine [1] | Rivastigmine (Exelon) [1] | Lecanemab (Leqembi), Donanemab (Kisunla) [1] |
| Frequency | Once or twice daily [1] | Once daily [1] | Bi-weekly or monthly [1] |
| Delivery | Swallowed pill or liquid [1] | Absorbed through the skin [1] | Direct injection into the vein [1] |
| Primary Use | Symptom management [1] | Symptom management [1] | Slowing disease progression [1] |
| Caregiver Effort | Can be challenging with memory loss or refusal [1] | Simple, but requires remembering daily application [1] | Transportation and time commitment for clinic visits [1] |
| Key Benefit | Widely available, often first-line treatment [1] | Improved adherence, fewer GI side effects [1] | Targets underlying disease pathology [1] |
| Key Consideration | Potential for missed doses or swallowing issues [1] | Risk of skin irritation [1] | Requires regular clinic visits, higher risk of ARIA [1] |
Caregiver and Patient Considerations
Selecting the right administration method is a shared decision based on the patient's stage of illness, swallowing ability, and side effect tolerance [1]. Caregivers play a crucial role in medication management [1].
Caregivers should:
- Understand the medications, including dosage and side effects [1].
- Establish a consistent routine [1].
- Use memory aids like pillboxes [1].
- Communicate with healthcare providers about any issues [1].
- Store medications safely [1].
Consulting resources like the Alzheimer's Association Medications Guide is recommended for current information on treatments [1].
Conclusion
Alzheimer's drugs are administered through oral, transdermal, and IV methods [1]. Oral and patch methods primarily manage symptoms, while IV infusions target disease progression [1]. The best method is personalized and determined in consultation with a healthcare provider [1]. Effective administration, supported by caregivers, is key to optimizing treatment and quality of life [1].